Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-02-01
2011-02-01
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S089000
Reexamination Certificate
active
07879871
ABSTRACT:
The invention relates to a new crystalline forms of tiotropium bromide, processes for preparing them and their use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.
REFERENCES:
patent: 3673195 (1972-06-01), Yoneda et al.
patent: 3808263 (1974-04-01), Yoneda et al.
patent: 4353922 (1982-10-01), Pfister
patent: 4855422 (1989-08-01), Grimminger et al.
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 6433027 (2002-08-01), Bozung et al.
patent: 6486321 (2002-11-01), Banholzer et al.
patent: 6506900 (2003-01-01), Banholzer et al.
patent: 6608055 (2003-08-01), Sieger et al.
patent: 6747154 (2004-06-01), Brandenburg et al.
patent: 6777423 (2004-08-01), Banholzer et al.
patent: 6908928 (2005-06-01), Banholzer et al.
patent: 2002/0110529 (2002-08-01), Bechtold-Peters et al.
patent: 2002/0111363 (2002-08-01), Drechsel et al.
patent: 2002/0133010 (2002-09-01), Banholzer et al.
patent: 2002/0193392 (2002-12-01), Schmelzer et al.
patent: 2002/0193394 (2002-12-01), Disse
patent: 2003/0171586 (2003-09-01), Banholzer et al.
patent: 2004/0002510 (2004-01-01), Bender et al.
patent: 2004/0018153 (2004-01-01), Schmelzer
patent: 2004/0039011 (2004-02-01), Disse
patent: 2004/0087793 (2004-05-01), Banholzer et al.
patent: 2005/0038252 (2005-02-01), Morschhaeuser et al.
patent: 2005/0143410 (2005-06-01), Pfrengle et al.
patent: 2006/0047120 (2006-03-01), Lock et al.
patent: 1 166 787 (1964-04-01), None
patent: 101 11 843 (2002-09-01), None
patent: 0 418 716 (1991-03-01), None
patent: 845056 (1960-08-01), None
patent: 955535 (1964-04-01), None
patent: 1350928 (1974-04-01), None
patent: 9011744 (1999-12-01), None
patent: 9011744 (1999-12-01), None
patent: WO 94/13262 (1994-06-01), None
patent: WO 00/07567 (2000-02-01), None
patent: WO 02/30928 (2002-04-01), None
patent: WO 02/30928 (2002-04-01), None
patent: WO 02/36104 (2002-05-01), None
patent: WO 02/38154 (2002-05-01), None
patent: WO 02/051840 (2002-07-01), None
patent: WO03/000265 (2003-01-01), None
U.S. Appl. No. 11/381,079, commonly assigned to Boehringer Ingelheim Corporation.
Atkinson, E.R. et al: “Parasympatholytic (Anticholinergic) Esters of the Isomeric 2-tropanols. 1. Glycolates”; J Med Chem; 1977, vol. 20, No. 12, pp. 1612-1617.
Disse, B. et al; “Tiotropium (Spiriva™): Mechanistical Considerations and Clinical Profile in Obstructive Lung Disease”; Life Sciences, vol. 64, Nos. 6/7, pp. 457-464, 1999, XP-002268933.
Foster, R. et al; “Further New Tropine Derivative”; Journal of the Chemical Society, (1957) pp. 3575-3578.
Petrovic, G. et al; “Synthesis of Acetyl Scopine. Intramolecular Reactions of N-Carbethoxy Nortropine-3alpha-benzenesulfenate”; Synlett, 1999, No. 5, pp. 635-637.
Stahl, P. H. et al, “Handbook of Pharmaceutical Salts Properties, Selection and use”, Wiley-VCH, Weinheim-New York (2002), p. 98 XP 002268934.
N-Butylscopolammonium Bromide Buscopan), Merck Index, 10th ed, pp. 219-220 (1983).
Ipratropium Bromide (Atrovent), Merck Index, 10th Ed., (1983), p. 733.
The Merck Index, 11th ed (1989), Merck and Co., Inc., pp. 242 and 802-803.
Accession Number (AN) : 1998:8089, USAN, Generic Name (CN) : Tiotropium Bromide, CAS Registry No. (RN) ; 139404-48-1, printout (“the USAN reference”) (1998).
Nyberg, Klas, et al; Preparation of Methyl Dithienylglycolates, Magnetically Nonequivalen Protons in Dithienylglycolates; Acta Chamica Scandinavica 24 (1970) No. 5 1590-1596.
Weiner, Norman, Goodman & Gilman, The Pharmacological Basis of Therapeutics, 6th Ed. p. 130, Valpin; (MacMillan 1980).
2010 USPC Official, Dec. 1, 2009-Sep. 30, 2010 General Chapters: <941> X-Ray Diffraction.
Houdayer Mulder Stéphanie
Lamkadmi Mimoun
Pop Mihaela Maria
Boehringer Ingelheim International GmbH
Chung Susannah
Morris Michael P.
Otton Alicia L
Petka Wendy A.
LandOfFree
Crystalline forms of tiotropium bromide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of tiotropium bromide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of tiotropium bromide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2620106